These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 30755341)
21. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study. Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469 [TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder. Vallo S; Gilfrich C; Burger M; Volkmer B; Boehm K; Rink M; Chun FK; Roghmann F; Novotny V; Mani J; Brisuda A; Mayr R; Stredele R; Noldus J; Schnabel M; May M; Fritsche HM; Pycha A; Martini T; Wirth M; Roigas J; Bastian PJ; Nuhn P; Dahlem R; Haferkamp A; Fisch M; Aziz A Urol Oncol; 2016 Oct; 34(10):432.e1-8. PubMed ID: 27283218 [TBL] [Abstract][Full Text] [Related]
23. Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis. García-Perdomo HA; Montes-Cardona CE; Guacheta M; Castillo DF; Reis LO World J Urol; 2018 Dec; 36(12):1997-2008. PubMed ID: 29943218 [TBL] [Abstract][Full Text] [Related]
24. Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study. Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Deuker M; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI Clin Genitourin Cancer; 2020 Apr; 18(2):117-128.e5. PubMed ID: 32035800 [TBL] [Abstract][Full Text] [Related]
25. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides. Reardon ZD; Patel SG; Zaid HB; Stimson CJ; Resnick MJ; Keegan KA; Barocas DA; Chang SS; Cookson MS Eur Urol; 2015 Jan; 67(1):165-170. PubMed ID: 24472710 [TBL] [Abstract][Full Text] [Related]
26. [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer]. Habuchi T; Kakehi Y; Terachi T; Ogawa O; Yoshida O Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):809-17. PubMed ID: 10565159 [TBL] [Abstract][Full Text] [Related]
27. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder. Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065 [TBL] [Abstract][Full Text] [Related]
29. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation. Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593 [TBL] [Abstract][Full Text] [Related]
30. Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy. Clifton MM; Psutka SP; Boorjian SA; Cheville JC; Thapa P; Thompson RH; Tollefson MK; Karnes RJ; Frank I World J Urol; 2015 Mar; 33(3):373-9. PubMed ID: 24833245 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [TBL] [Abstract][Full Text] [Related]
32. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer. Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998 [TBL] [Abstract][Full Text] [Related]
33. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204 [TBL] [Abstract][Full Text] [Related]
34. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849 [TBL] [Abstract][Full Text] [Related]
35. Contemporary 90-day mortality rates after radical cystectomy in the elderly. Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826 [TBL] [Abstract][Full Text] [Related]
36. Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy. Faiena I; Salmasi A; Mendhiratta N; Lenis AT; Pooli A; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K World J Urol; 2018 Nov; 36(11):1825-1833. PubMed ID: 29752514 [TBL] [Abstract][Full Text] [Related]
37. Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy. Moschini M; Mattei A; Cornelius J; Shariat SF; Dell'Oglio P; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A World J Urol; 2018 Apr; 36(4):639-644. PubMed ID: 29368231 [TBL] [Abstract][Full Text] [Related]
38. Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intent. Horn T; Schmid SC; Seitz AK; Grab J; Wolf P; Haller B; Retz M; Maurer T; Autenrieth M; Kübler HR; Gschwend JE World J Urol; 2015 Jun; 33(6):813-9. PubMed ID: 25007992 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data. Audenet F; Waingankar N; Ferket BS; Niglio SA; Marqueen KE; Sfakianos JP; Galsky MD J Urol; 2018 Nov; 200(5):996-1004. PubMed ID: 29879397 [TBL] [Abstract][Full Text] [Related]
40. Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy. de Angelis M; Scheipner L; Siech C; Jannello LMI; Baudo A; Bello FD; Goyal JA; Vitucci K; Tian Z; Longo N; Ahyai S; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Gandaglia G; Moschini M; Montorsi F; Briganti A; Karakiewicz PI Clin Genitourin Cancer; 2024 Aug; 22(4):102119. PubMed ID: 38852435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]